RECENSA THERAPEUTICS

Recensa is developing small molecules that activate the transcription factor Nrf2, a key modulator of antioxidant response. These molecules will be embedded in topical vehicles-such as creams or lotions-and will be tested in animal models of psoriasis so we can gain FDA approval for human clinical trials. Future products may target other diseases where oxidative stress is a key factor
RECENSA THERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2016-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.recensatherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
77 K USD
Technology used in webpage:
SPF Namecheap DNS Namecheap Hosting Namecheap
Similar Organizations
Black Belt Therapeutics
Black Belt Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.
Cystinosis Research Foundation
Cystinosis Research Foundation supports bench, clinical, and translational research to find therapeutics for cystinosis.
Decedario
Decedario is a therapeutic board game for cognitive stimulation.
DNAdigest
DNAdigest is a scientific social enterprise that enables the secure sharing and query of genomics data for research.
Genome Explorations
Genome Explorations is a research institution that provides global genomic profiling and molecular diagnostics services.
Gentec
Gentec managed to create things like the first private laboratory to do a genetic edition using CRISPR-Cas9 technology in Mexico.
M. STEVES USA
Products that Perform beautyfully to visibly improve skin
PSMA Therapeutics
PSMA Therapeutics is a subsidiary of Noria to advance the platform of prostate-specific membrane antigen (PSMA) targeting radiotherapeutics.
Ventrinova
VentriNova is revolutionizing cardiac regenerative medicine by reversing cardiac damage pharmacologically.
Current Employees Featured
Founder
Investors List
Phase 1 Ventures
Phase 1 Ventures investment in Pre Seed Round - Recensa Therapeutics
Phase One Ventures
Phase One Ventures investment in Pre Seed Round - Recensa Therapeutics
Phase 1 Ventures
Phase 1 Ventures investment in Pre Seed Round - Recensa Therapeutics
Official Site Inspections
http://www.recensatherapeutics.com
Unable to get host informations!!!

More informations about "Recensa Therapeutics"
ABOUT US - CONNECTA Therapeutics
The company was founded in July 2019 as a spin-off of Prous Institute Biomedical Research, a private research organization based in Barcelona. In September 2020, we completed a seed round led by the founders, Inveready, โฆSee details»
Our Team โ Resalis Therapeutics
As part of her commitment to therapeutic innovation in the metabolic space, Almut also served as a Management Board Member at INNODIA, an international non-profit organization โฆSee details»
RECENSA THERAPEUTICS, INC. in Wilmington, DE - Bizapedia
Apr 25, 2025 Discover Company Info on RECENSA THERAPEUTICS, INC. in Wilmington, DE, such as Contacts, Addresses, Reviews, and Registered Agent.See details»
Leadership Team - Revance
Revanceโs leadership is committed to disrupting the status quo and has deep experience commercializing products in highly competitive markets.See details»
Similar companies to Recensa Therapeutics | VentureRadar
Companies like Recensa Therapeutics. Similar companies and competitors in the areas of Small Molecule Pharmaceuticals and more.See details»
Atsena Therapeutics
Jul 9, 2025 Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.See details»
Top 15 Contract Research Organizations (CROs) in โฆ
In early 2022, CATO SMS merged with Pharm-Olam, a global clinical research organization delivering clinical trial services to organizations around the world. KCR โ 0.15 billion USD, 700 employees KCR is a clinical development โฆSee details»
Recensa Therapeutics, Inc. - CAGE.report
Inc. Recensa Therapeutics has a registered in the System for Award Management for doing business with and bidding for contracts by the United States government. Cage Code 7P0B7 โฆSee details»
Recensa Therapeutics, Inc. | (484) 802-7419 | Philadelphia - AllBiz
Matthew Handel is the primary contact at Recensa Therapeutics, Inc.. Recensa Therapeutics, Inc. generates approximately USD 47,230 in revenue annually, and employs around 1 person at โฆSee details»
Recensa Therapeutics - Golden
Recensa Therapeutics is a Philadelphia County, Pennsylvania-based company.See details»
About Us | EVERSANA
4 days ago EVERSANA is a leading independent provider of global services to the life sciences industry. The companyโs integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long โฆSee details»
813159327 EIN/TAX ID | RECENSA THERAPEUTICS INC - HIPAASpace
An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used to identify a business entity. Generally, businesses need an EIN. Business Name โฆSee details»
Oscar Perez-Leal - Co founder @ Recensa Therapeutics - Crunchbase
Oscar Perez-Leal has 3 current jobs including Assistant Professor at Temple University, Co founder at Recensa Therapeutics, and Co-founder at ExpressCells.See details»
Recensa Therapeutics headquarters and office locations - Craft
Recensa Therapeutics Corporate Headquarters, Office Locations and Addresses | Craft.coHome / Recensa Therapeutics / Locations Recensa Therapeutics Overview Locations Financials โฆSee details»
Recensa Therapeutics 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Recensa Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Recombinetics Merges with Makana Therapeutics to Accelerate ...
According to Mark Platt, President and CEO of Recombinetics Inc., โMakana Therapeutics is the ideal fit for our organization โ this is a force multiplier. With our combined strengths & โฆSee details»
Recensa Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Recensa Therapeutics, Inc. of Philadelphia, PA. Get the latest business insights from Dun & Bradstreet.See details»
Best healthcare provider | Resona Pharmaceuticals
Resona Pharmaceuticals is the Best healthcare provider with a science-driven global healthcare organization with a single mission: to empower people to do more, feel better, and live longer. โฆSee details»
Our Company โ Inspirna
Our Mission Target previously untreatable common cancers with small molecules and biologics by exposing newly discovered drivers of metastasis. Through our proprietary and clinically โฆSee details»
RNA Therapeutics - IQVIA
Introduction In our second blog, we looked at how one transformational technology โ CRISPR โ has been shaping the advanced therapies landscape. Since that publication, the UKโs MHRA โฆSee details»